Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-10-17
2025-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Food As Medicine for Heart Failure
NCT04847973
Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease
NCT02075710
The Effect of Medium-chain Fatty Acids on Cardiac Function
NCT06399354
Nutritional Determinants of Cardiovascular Disease
NCT00005247
Combined Effects of Meal Frequency and Protein Load on Cardiometabolic Risk Factors
NCT02529228
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
15 Medically Tailored Meals (MTM) + snacks
Participants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks.
15 Medically Tailored Meals (MTM) per week
15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday.
14 Medically Tailored Meals (MTM)
Participants will receive 14 medically tailored meals (MTM) per week for 12 weeks.
14 Medically Tailored Meals (MTM) per week
14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
15 Medically Tailored Meals (MTM) per week
15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday.
14 Medically Tailored Meals (MTM) per week
14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living in San Diego or the Bay Area of California
* Reported congestive heart failure (CHF) diagnosis
* Current diet can be improved
* Willing to eat all meals provided by the study
Exclusion Criteria
* Diagnosed with diabetes (type 1 or uncontrolled type 2)
* Currently taking insulin and/or meglitinides medications
* Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
* Hemoglobin A1c (HbA1c) results \>8 %
* Life expectancy of \<1 year
* Pregnancy or lactation
* Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen
* Current smoker or tobacco use within the past year
* Planning to leave San Diego or the Bay Area during the course of the study
* Unable to communicate reasonably well either orally or through written material in English
* Those who, in the opinion of the investigators, cannot reliably complete the study protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cheryl A. Anderson, MPH, PhD
Professor and Dean
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cheryl Anderson, PhD, MPH, MS
Role: PRINCIPAL_INVESTIGATOR
UC San Diego
Christopher Gardner, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Diego
La Jolla, California, United States
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24RPGFIM1198191
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.